Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ·Healthcare·Biotechnology
$4.50
+3.10%
Mkt Cap $340.12M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+122.5%
Consensus $10.00 vs current $4.50
NASDAQ·Healthcare·Biotechnology
$4.50
+3.10%
Mkt Cap $340.12M
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$10.00
Range $10.00 – $10.00
+122.5%
Consensus $10.00 vs current $4.50